Cabaletta Bio Inc (CABA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -167,856 | -115,864 | -67,675 | -52,975 | -46,289 |
| Depreciation Amortization | 12,320 | 3,690 | 612 | 1,640 | 795 |
| Accounts payable and accrued liabilities | 1,550 | 1,011 | 1,675 | -28 | 975 |
| Other Working Capital | -379 | 1,611 | 101 | -4,299 | 5,639 |
| Other Operating Activity | 23,285 | 21,330 | 11,738 | 9,282 | 4,771 |
| Operating Cash Flow | $-131,080 | $-88,222 | $-53,549 | $-46,380 | $-34,109 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,229 | -2,211 | -687 | -2,453 | -1,166 |
| Purchase Of Investment | -49,037 | 49,500 | -21,764 | -24,764 | 7,165 |
| Investing Cash Flow | $-50,266 | $47,289 | $-22,451 | $-27,217 | $5,999 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -6,261 | -897 | N/A | N/A | N/A |
| Common Stock Issued | 106,608 | 12,574 | 187,631 | 32,982 | 48,903 |
| Financing Cash Flow | $100,347 | $11,677 | $187,631 | $32,982 | $48,903 |
| Exchange Rate Effect | 19 | -20 | N/A | N/A | N/A |
| Beginning Cash Position | 163,962 | 193,238 | 81,607 | 122,222 | 101,429 |
| End Cash Position | 82,982 | 163,962 | 193,238 | 81,607 | 122,222 |
| Net Cash Flow | $-80,980 | $-29,276 | $111,631 | $-40,615 | $20,793 |
| Free Cash Flow | |||||
| Operating Cash Flow | -131,080 | -88,222 | -53,549 | -46,380 | -34,109 |
| Capital Expenditure | -1,229 | -2,211 | -687 | -2,453 | -1,166 |
| Free Cash Flow | -132,309 | -90,433 | -54,236 | -48,833 | -35,275 |